BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31972251)

  • 1. Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.
    Braun AD; Mengoni M; Bonifatius S; Tüting T; Gaffal E
    J Invest Dermatol; 2020 Jul; 140(7):1410-1417.e2. PubMed ID: 31972251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
    Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
    Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
    Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition.
    Zimmer L; Hillen U; Livingstone E; Lacouture ME; Busam K; Carvajal RD; Egberts F; Hauschild A; Kashani-Sabet M; Goldinger SM; Dummer R; Long GV; McArthur G; Scherag A; Sucker A; Schadendorf D
    J Clin Oncol; 2012 Jul; 30(19):2375-83. PubMed ID: 22614973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of activated c-Met with NRAS-mutated human melanomas.
    Chattopadhyay C; Ellerhorst JA; Ekmekcioglu S; Greene VR; Davies MA; Grimm EA
    Int J Cancer; 2012 Jul; 131(2):E56-65. PubMed ID: 22020736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma.
    Beretti F; Farnetani F; Reggiani Bonetti L; Fabbiani L; Zavatti M; Maiorana A; Pellacani G; Maraldi T
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.
    Tormo D; Ferrer A; Gaffal E; Wenzel J; Basner-Tschakarjan E; Steitz J; Heukamp LC; Gütgemann I; Buettner R; Malumbres M; Barbacid M; Merlino G; Tüting T
    Am J Pathol; 2006 Aug; 169(2):665-72. PubMed ID: 16877364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF
    McNeal AS; Belote RL; Zeng H; Urquijo M; Barker K; Torres R; Curtin M; Shain AH; Andtbacka RH; Holmen S; Lum DH; McCalmont TH; VanBrocklin MW; Grossman D; Wei ML; Lang UE; Judson-Torres RL
    Elife; 2021 Nov; 10():. PubMed ID: 34812139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.
    Jubb AM; Ribas A; Sosman JA; McArthur GA; Yan Y; Rost S; Zhao S; Koeppen H
    Histopathology; 2013 Sep; 63(3):351-61. PubMed ID: 23802768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
    Ruiz-Vega R; Chen CF; Razzak E; Vasudeva P; Krasieva TB; Shiu J; Caldwell MG; Yan H; Lowengrub J; Ganesan AK; Lander AD
    Elife; 2020 Oct; 9():. PubMed ID: 33047672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice.
    Gaffal E; Landsberg J; Bald T; Sporleder A; Kohlmeyer J; Tüting T
    Int J Cancer; 2011 Jul; 129(2):285-94. PubMed ID: 21207411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
    Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
    PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.
    de Keizer PL; Packer LM; Szypowska AA; Riedl-Polderman PE; van den Broek NJ; de Bruin A; Dansen TB; Marais R; Brenkman AB; Burgering BM
    Cancer Res; 2010 Nov; 70(21):8526-36. PubMed ID: 20959475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
    Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
    Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
    Chagani S; Wang R; Carpenter EL; Löhr CV; Ganguli-Indra G; Indra AK
    BMC Cancer; 2017 Nov; 17(1):736. PubMed ID: 29121869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasma membrane Ca
    Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
    Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma.
    Wolnicka-Glubisz A; Strickland FM; Wielgus A; Anver M; Merlino G; De Fabo EC; Noonan FP
    Int J Cancer; 2015 Feb; 136(4):752-60. PubMed ID: 24975581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.